Lipidomics, a platform developed by Creative Proteomics, is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomic services for biomedical research institutions and biotechnological and pharmaceutical companies.
Lipidomics, a platform developed by Creative Proteomics, is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomic services for biomedical research institutions and biotechnological and pharmaceutical companies. The company recently announced the launch of the ceramides analysis service to help effectively and accurately detect the modification content of ceramides.
Ceramide is the central hub of the sphingolipid pathway, which includes sphingomyelin, glucosylceramide, and galactosylceramide. It is further divided into hexose ceramide (HexCer), lactose ceramide (LacCer), sphingosine (Sph), dihydro sphingosine (DhSph), and dihydroceramide (DhCer). Ceramide has a solid ability to associate with water molecules, thus maintaining skin moisture by forming a network structure in the stratum corneum. In addition, ceramide also plays an essential role in maintaining the integrity of cell membranes, cell stress response, inflammatory signal transduction, and cell apoptosis.
Ceramide is a class of important biologically active substances. It acts as a second messenger molecule in the metabolism of sphingolipids in the nervous system and is involved in activating a variety of stress-related enzymes and mediating apoptosis. Meanwhile, sphingolipid is a class of phospholipids consisting of the ceramide backbone and has a variety of physiological and pharmacological functions, such as regulating cellular immunity, delaying aging, and acting as an anti-tumor agent.
The Lipidomic platform employs the liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) method, which implies the QTRAP 4500 LC-MS/MS system for the efficient and accurate detection of ceramide content changes. Currently, some detectable ceramides (Cer) include HexCer, LacCer, Sph, DhSph, DhCer, Cer(d14:1/16:0), Cer(d14:1/22:0), Cer(d15:1/20:0), etc.
“Our Lipidomic platform is based on the high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) synchronized with other cutting-edge technologies. Hence, we use the LC-MS/MS technology to simultaneously determine the content of more than 23 types of ceramides in various sample types, providing technical support for comprehensive analysis of intracellular ceramide content. This method has high sensitivity and fast detection turnaround, thus efficiently and accurately detecting the content change of ceramides,” commented a senior scientist at Creative Proteomics.
“Our platform is equipped with advanced instruments, including GC-MS, LC-MS, LC-MS/MS, shot-gun, MALDI-MS, etc. With highly specialized technical capabilities and professional knowledge derived from mass spectrometry experts, we are fully prepared to cooperate in the rapid development of the field of lipidomic and, at the same time, support researchers from research design to the final report,” he further added.
About Creative Proteomics
Creative Proteomics has gradually grown into an integrated service provider with targeted lipidomics and untargeted lipidomics analysis services for researchers in the pharmaceutical, biotechnology, agriculture, and nutrition industries, as well as academic and government organizations.
Contact:
Address: Shirley, NY 11967, USA